MP25-16 MEDICATION SWITCHING AFTER INITIAL PHARMACOTHERAPY FOR OVERACTIVE BLADDER

dc.contributor.author	Scales, Charles
dc.contributor.author	Greiner, Melissa
dc.contributor.author	Curtis, Lesley
dc.contributor.author	Hammill, Brad
dc.contributor.author	Peterson, Andrew
dc.contributor.author	Amundsen, Cindy
dc.contributor.author	Martinez-Bianchi, Viviana
dc.contributor.author	Heflin, Mitchell
dc.contributor.author	Schmader, Kenneth
dc.date.accessioned	2016-10-05T16:30:25Z
dc.date.available	2016-10-05T16:30:25Z
dc.date.issued	2016-04
dc.identifier.issn	0022-5347
dc.identifier.uri	https://hdl.handle.net/10161/12930
dc.publisher	Ovid Technologies (Wolters Kluwer Health)
dc.relation.ispartof	The Journal of Urology
dc.relation.isversionof	10.1016/j.juro.2016.02.793
dc.title	MP25-16 MEDICATION SWITCHING AFTER INITIAL PHARMACOTHERAPY FOR OVERACTIVE BLADDER
dc.type	Journal article
duke.contributor.orcid	Curtis, Lesley\|0000-0002-3286-9371
duke.contributor.orcid	Martinez-Bianchi, Viviana\|0000-0003-4614-7916
duke.contributor.orcid	Schmader, Kenneth\|0000-0001-5036-2155
pubs.begin-page	e285
pubs.issue	4
pubs.organisational-group	Clinical Science Departments
pubs.organisational-group	Community and Family Medicine
pubs.organisational-group	Community and Family Medicine, Family Medicine
pubs.organisational-group	Duke
pubs.organisational-group	School of Medicine
pubs.publication-status	Published
pubs.volume	195

Files

Now showing 1 - 1 of 1